Hengyu Chen

1.6k total citations
46 papers, 1.1k citations indexed

About

Hengyu Chen is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hengyu Chen has authored 46 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 19 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hengyu Chen's work include Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (10 papers) and Epigenetics and DNA Methylation (9 papers). Hengyu Chen is often cited by papers focused on Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (10 papers) and Epigenetics and DNA Methylation (9 papers). Hengyu Chen collaborates with scholars based in China, United States and Hong Kong. Hengyu Chen's co-authors include Ye Zeng, Mingliang Liu, Gang Zhao, Zhu Zeng, Shi-Jiang Deng, Chunyou Wang, Jianxin Zhong, Ruoyan Li, Fan Bai and Xianxiong Ma and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer Research.

In The Last Decade

Hengyu Chen

43 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hengyu Chen China 19 646 453 165 133 114 46 1.1k
Yanan Lu China 18 617 1.0× 429 0.9× 172 1.0× 78 0.6× 119 1.0× 42 1.0k
Jianjun Liu China 19 746 1.2× 508 1.1× 154 0.9× 93 0.7× 40 0.4× 32 1.1k
Yanyan Shen China 21 824 1.3× 293 0.6× 219 1.3× 138 1.0× 48 0.4× 63 1.2k
Mihail I. Mitov United States 15 545 0.8× 340 0.8× 109 0.7× 110 0.8× 78 0.7× 26 1.0k
Sung‐Gil Chi South Korea 19 732 1.1× 214 0.5× 234 1.4× 122 0.9× 76 0.7× 32 1.1k
Yifei Xing China 20 693 1.1× 415 0.9× 168 1.0× 231 1.7× 57 0.5× 65 1.1k
Ronald C. Hendrickson United States 15 919 1.4× 265 0.6× 280 1.7× 190 1.4× 68 0.6× 17 1.4k
Chaoyu Wang China 23 798 1.2× 265 0.6× 199 1.2× 188 1.4× 153 1.3× 83 1.5k
Jin‐Fei Lin China 12 1.0k 1.6× 784 1.7× 148 0.9× 232 1.7× 52 0.5× 24 1.5k

Countries citing papers authored by Hengyu Chen

Since Specialization
Citations

This map shows the geographic impact of Hengyu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hengyu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hengyu Chen more than expected).

Fields of papers citing papers by Hengyu Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hengyu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hengyu Chen. The network helps show where Hengyu Chen may publish in the future.

Co-authorship network of co-authors of Hengyu Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Hengyu Chen. A scholar is included among the top collaborators of Hengyu Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hengyu Chen. Hengyu Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Jin, Wenwen Wang, Lei Hao, et al.. (2025). Targeting PSMD14 combined with arachidonic acid induces synthetic lethality via FADS1 m 6 A modification in triple-negative breast cancer. Science Advances. 11(19). eadr3173–eadr3173. 2 indexed citations
2.
Hao, Lei, Jin Hu, Junpeng Zhu, et al.. (2025). Global research prospects and trends in TFH cells and tumors: a bibliometric analysis. Frontiers in Oncology. 15. 1443890–1443890.
3.
Zhao, Ning, Yinghao Cao, Kaixiong Tao, et al.. (2024). The circMYBL2-Encoded p185 Protein Suppresses Colorectal Cancer Progression by Inhibiting Serine Biosynthesis. Cancer Research. 84(13). 2155–2168. 8 indexed citations
4.
Dai, Shu-Zhen, Hengyu Chen, Minghui Chen, et al.. (2024). Progesterone suppresses rhinovirus-induced airway inflammation by inhibiting neutrophil infiltration and extracellular traps formation. International Immunopharmacology. 144. 113714–113714. 2 indexed citations
5.
Xi, Zihan, Haohao Huang, Jin Hu, et al.. (2024). LINC00571 drives tricarboxylic acid cycle metabolism in triple-negative breast cancer through HNRNPK/ILF2/IDH2 axis. Journal of Experimental & Clinical Cancer Research. 43(1). 22–22. 12 indexed citations
6.
Zhang, Wenhui, et al.. (2023). Study on Plugging Material and Plugging Mechanism of Crude Oil Sand Water Filter Pipe. Water. 15(21). 3714–3714.
7.
Chen, Hengyu, Ming Yang, Haohao Huang, et al.. (2022). YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner. Cell & Bioscience. 12(1). 19–19. 80 indexed citations
8.
Huang, Feng‐Ying, Shu-Zhen Dai, Wentian Xu, et al.. (2022). 3′-epi-12β-hydroxyfroside-mediated autophagy degradation of RIPK1/RIPK3 necrosomes leads to anergy of immunogenic cell death in triple-negative breast cancer cells. Pharmacological Research. 187. 106613–106613. 23 indexed citations
9.
Ma, Xianxiong, et al.. (2021). CircGSK3B promotes RORA expression and suppresses gastric cancer progression through the prevention of EZH2 trans-inhibition. Journal of Experimental & Clinical Cancer Research. 40(1). 330–330. 36 indexed citations
10.
Xi, Zihan, et al.. (2021). A Metabolic-associated Nomogram Predicts Recurrence Survival of Thyroid Cancer. Current Medical Science. 41(5). 1004–1011. 1 indexed citations
11.
Ma, Xianxiong, et al.. (2020). DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical management. Journal of Cellular and Molecular Medicine. 24(13). 7576–7589. 17 indexed citations
12.
Shi, Jianhui, Junyu Lu, Hengyu Chen, et al.. (2020). Liver ChREBP Protects Against Fructose-Induced Glycogenic Hepatotoxicity by Regulating L-Type Pyruvate Kinase. Diabetes. 69(4). 591–602. 34 indexed citations
13.
Shi, Yanan, Da Pan, Lihui Yan, et al.. (2020). Salvianolic acid B improved insulin resistance through suppression of hepatic ER stress in ob/ob mice. Biochemical and Biophysical Research Communications. 526(3). 733–737. 19 indexed citations
14.
Li, Ruoyan, Hengyu Chen, Kimiko Della Croce, et al.. (2019). Graded regulation of cellular quiescence depth between proliferation and senescence by a lysosomal dimmer switch. Proceedings of the National Academy of Sciences. 116(45). 22624–22634. 91 indexed citations
15.
Zhang, Jingyu, Hengyu Chen, Ruoyan Li, et al.. (2019). Spatial clustering and common regulatory elements correlate with coordinated gene expression. PLoS Computational Biology. 15(3). e1006786–e1006786. 17 indexed citations
16.
17.
Deng, Shi-Jiang, Hengyu Chen, Zhu Zeng, et al.. (2018). Nutrient Stress–Dysregulated Antisense lncRNA GLS-AS Impairs GLS-Mediated Metabolism and Represses Pancreatic Cancer Progression. Cancer Research. 79(7). 1398–1412. 103 indexed citations
18.
Niu, Yi, Yan Jin, Shichang Deng, et al.. (2018). MiRNA-646-mediated reciprocal repression between HIF-1α and MIIP contributes to tumorigenesis of pancreatic cancer. Oncogene. 37(13). 1743–1758. 46 indexed citations
19.
Li, Jie, Kaerdun Liu, Hengyu Chen, et al.. (2017). Functional Built-In Template Directed Siliceous Fluorescent Supramolecular Vesicles as Diagnostics. ACS Applied Materials & Interfaces. 9(26). 21706–21714. 38 indexed citations
20.
Zhou, Na, et al.. (2013). Recent advances in lanthanide-doped upconversion nanomaterials: synthesis, nanostructures and surface modification. Nanoscale. 5(23). 11512–11512. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026